111 related articles for article (PubMed ID: 22260647)
1. Prodrugs of acyclovir--a computational approach.
Karaman R; Dajani KK; Qtait A; Khamis M
Chem Biol Drug Des; 2012 May; 79(5):819-34. PubMed ID: 22260647
[TBL] [Abstract][Full Text] [Related]
2. Computer-assisted design for atenolol prodrugs for the use in aqueous formulations.
Karaman R; Dajani K; Hallak H
J Mol Model; 2012 Apr; 18(4):1523-40. PubMed ID: 21785934
[TBL] [Abstract][Full Text] [Related]
3. Prodrugs for masking bitter taste of antibacterial drugs--a computational approach.
Karaman R
J Mol Model; 2013 Jun; 19(6):2399-412. PubMed ID: 23420399
[TBL] [Abstract][Full Text] [Related]
4. Computer-assisted design of pro-drugs for antimalarial atovaquone.
Karaman R; Hallak H
Chem Biol Drug Des; 2010 Oct; 76(4):350-60. PubMed ID: 20731669
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the acid-catalyzed hydrolysis of acyclovir and an ester prodrug in aqueous solution.
Jensen E; Bundgaard H
Acta Pharm Nord; 1991; 3(3):147-50. PubMed ID: 1793509
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
[TBL] [Abstract][Full Text] [Related]
7. Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.
Diez-Torrubia A; Cabrera S; de Castro S; García-Aparicio C; Mulder G; De Meester I; Camarasa MJ; Balzarini J; Velázquez S
Eur J Med Chem; 2013; 70():456-68. PubMed ID: 24185376
[TBL] [Abstract][Full Text] [Related]
8. Prodrugs of aza nucleosides based on proton transfer reaction.
Karaman R
J Comput Aided Mol Des; 2010 Dec; 24(12):961-70. PubMed ID: 20941527
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations.
Karaman R; Qtait A; Dajani KK; Abu Lafi S
ScientificWorldJournal; 2014; 2014():248651. PubMed ID: 24526887
[TBL] [Abstract][Full Text] [Related]
10. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
Anand BS; Katragadda S; Nashed YE; Mitra AK
Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors.
Katragadda S; Talluri RS; Mitra AK
Int J Pharm; 2006 Aug; 320(1-2):104-13. PubMed ID: 16720085
[TBL] [Abstract][Full Text] [Related]
12. Cyclopropanecarboxylic acid esters as potential prodrugs with enhanced hydrolytic stability.
Bender DM; Peterson JA; McCarthy JR; Gunaydin H; Takano Y; Houk KN
Org Lett; 2008 Feb; 10(3):509-11. PubMed ID: 18181639
[TBL] [Abstract][Full Text] [Related]
13. Computational-aided design for dopamine prodrugs based on novel chemical approach.
Karaman R
Chem Biol Drug Des; 2011 Nov; 78(5):853-63. PubMed ID: 21824329
[TBL] [Abstract][Full Text] [Related]
14. Computationally designed prodrugs of statins based on Kirby's enzyme model.
Karaman R; Amly W; Scrano L; Mecca G; Bufo SA
J Mol Model; 2013 Sep; 19(9):3969-82. PubMed ID: 23835602
[TBL] [Abstract][Full Text] [Related]
15. Controllable synthesis of polymerizable ester and amide prodrugs of acyclovir by enzyme in organic solvent.
Li X; Wu Q; Lv DS; Lin XF
Bioorg Med Chem; 2006 May; 14(10):3377-82. PubMed ID: 16431120
[TBL] [Abstract][Full Text] [Related]
16. Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface.
Sarpietro MG; Rocco F; Micieli D; Ottimo S; Ceruti M; Castelli F
Int J Pharm; 2010 Aug; 395(1-2):167-73. PubMed ID: 20635474
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions.
Karaman R; Ghareeb H; Dajani KK; Scrano L; Hallak H; Abu-Lafi S; Mecca G; Bufo SA
J Comput Aided Mol Des; 2013 Jul; 27(7):615-35. PubMed ID: 23881217
[TBL] [Abstract][Full Text] [Related]
18. Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits.
Stella B; Arpicco S; Rocco F; Burgalassi S; Nicosia N; Tampucci S; Chetoni P; Cattel L
Eur J Pharm Biopharm; 2012 Jan; 80(1):39-45. PubMed ID: 22008147
[TBL] [Abstract][Full Text] [Related]
19. Stability of valacyclovir: implications for its oral bioavailability.
Granero GE; Amidon GL
Int J Pharm; 2006 Jul; 317(1):14-8. PubMed ID: 16759825
[TBL] [Abstract][Full Text] [Related]
20. Theoretical studies on the hydrolysis mechanism of N-(2-oxo-1,2-dihydro-pyrimidinyl) formamide.
Wu Y; Xue Y; Xie DQ; Kim CK; Yan GS
J Phys Chem B; 2007 Mar; 111(9):2357-64. PubMed ID: 17295531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
